New screening approach uncovers potential alternative drug therapies for neuroblastoma

(Cell Press) Nearly two-thirds of patients with high-risk neuroblastoma -- a common tumor that forms in the nerve cells of children -- cannot be cured using tumor-killing cancer drugs. A study published in Chemistry & Biology reveals a new genomic approach to screen for compounds that inhibit tumor growth by causing cancer cells to differentiate. Using this screening method, the researchers identified a compound that causes neuroblastoma cells to differentiate, uncovering promising new treatment strategies.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news